Medicine
Korlym 300 mg tablet
Korlym 300 mg tablet is a prescription medicine containing Mifepristone for oral use, marketed by Corcept Therapeutics, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Ambient
Store at controlled room temperature, 25 °C (77 °F), excursions permitted to…
Key facts
- Active ingredient (INN)
- Mifepristone
- Brand
- Korlym
- Strength
- 300 mg
- Dosage form
- Tablet
- Route
- Oral
- Packs
- 28 tablets, 280 tablets
- Marketing authorisation holder
- Corcept Therapeutics
- Manufacturer
- Corcept Therapeutics
- Origin register
- US FDA, United States
- Storage
- Store at controlled room temperature, 25 °C (77 °F), excursions permitted to 15 to 30 °C (59 – 86 °F).
- Cold chain
- Not required on record
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- G03XB01 Mifepristone
- HS code (indicative)
- 3004.39Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 17 February 2012
- Identifiers
- RxCUI 1245262, 1245268DailyMed set ID 542f3fae-8bc8-4f00-9228-e4b66c9ad6a9NDC 76346-073Application NDA202107
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 28 tablet in 1 bottle | 76346-073-01 | Corcept Therapeutics | 17 February 2012 |
| 280 tablet in 1 bottle | 76346-073-02 | Corcept Therapeutics | 17 February 2012 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Mifepristone 300 mg tablet.
Other strengths and forms of Mifepristone
Clinical summary
Mifepristone is a progestin antagonist indicated to control hyperglycemia secondary to hypercortisolism in adult patients with endogenous Cushing's syndrome, among other approved uses. It is available as tablets for oral use. MedsAcross supplies Mifepristone for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about MifepristoneFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- Mifepristone prescribing information (Corcept Therapeutics) · U.S. National Library of Medicine, DailyMed
Need Korlym 300 mg tablet for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.